[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![CorleoneDon77 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1577382889104318472.png) DonCorleone77 [@CorleoneDon77](/creator/twitter/CorleoneDon77) on x 5286 followers
Created: 2025-06-23 11:06:38 UTC

$PTCT PTC Therapeutics announces Sephience granted marketing authorization by EC

PTC Therapeutics announced that Sephience was granted marketing authorization by the European Commission, EC, for the treatment of children and adults living with phenylketonuria, PKU. The authorization includes a broad label inclusive of all ages and disease severities. "The European approval of Sephience is a great step in our efforts to bring this safe and highly effective therapy to children and adults affected by PKU worldwide," said Matthew Klein, M.D., Chief Executive Officer of PTC Therapeutics. "The broad label supports that potential for Sephience to address all key PKU patient segments and become the new standard of care."


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1937105008673075226/c:line.svg)

**Related Topics**
[$ptct](/topic/$ptct)

[Post Link](https://x.com/CorleoneDon77/status/1937105008673075226)